Literature DB >> 23946869

GT198 Splice Variants Display Dominant-Negative Activities and Are Induced by Inactivating Mutations.

Min Peng1, Zheqiong Yang, Hao Zhang, Lahcen Jaafar, Guanghu Wang, Min Liu, Hernan Flores-Rozas, Jianming Xu, Nahid F Mivechi, Lan Ko.   

Abstract

Alternative pre-mRNA splicing yields functionally distinct splice variants in regulating normal cell differentiation as well as cancer development. The putative tumor suppressor gene GT198 (PSMC3IP), encoding a protein also known as TBPIP and Hop2, has been shown to regulate steroid hormone receptor-mediated transcription and to stimulate homologous recombination in DNA repair. Here, we have identified 6 distinct GT198 splice variant transcripts generated by alternative promoter usage or alternative splicing. Various splice variant transcripts preserve a common open reading frame, which encodes the DNA binding domain of GT198. The splice variants act as dominant negatives to counteract wild-type GT198 activity in transcription and to abolish Rad51 foci formation during radiation-induced DNA damage. In fallopian tube cancer, we have identified 44 point mutations in GT198 clustered in 2 mutation hotspot sequences. The mutation hotspots coincide with the regulatory sequences responsible for alternative splicing, strongly supporting that imbalanced alternative splicing is a selected consequence in cancer. In addition, splice variant-associated cytoplasmic expression is found in tumors carrying germline or somatic GT198 mutations. An altered alternative splicing pattern with increased variants is also present in lymphoblastoid cells derived from familial breast cancer patients carrying GT198 germline mutations. Furthermore, GT198 and its variant are reciprocally expressed during mouse stem cell differentiation. The constitutive expression of the GT198 variant but not the wild type induces tumor growth in nude mice. Our results collectively suggest that mutations in the GT198 gene deregulate alternative splicing. Defective alternative splicing promotes antagonizing variants and in turn induces a loss of the wild type in tumorigenesis. The study highlights the role of alternative splicing in tumor suppressor gene inactivation.

Entities:  

Keywords:  DNA repair; GT198; alternative splicing; somatic mutation; tumor suppressor gene

Year:  2013        PMID: 23946869      PMCID: PMC3743156          DOI: 10.1177/1947601913486345

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  53 in total

Review 1.  Expression of BRCA1 and BRCA2 in normal and neoplastic cells.

Authors:  L A Chodosh
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

2.  Identification and characterization of a tissue-specific coactivator, GT198, that interacts with the DNA-binding domains of nuclear receptors.

Authors:  Lan Ko; Guemalli R Cardona; Alexandra Henrion-Caude; William W Chin
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  The Hop2 and Mnd1 proteins act in concert with Rad51 and Dmc1 in meiotic recombination.

Authors:  Galina V Petukhova; Roberto J Pezza; Filip Vanevski; Mickael Ploquin; Jean-Yves Masson; R Daniel Camerini-Otero
Journal:  Nat Struct Mol Biol       Date:  2005-04-17       Impact factor: 15.369

4.  Generation of a transcription map at the HSD17B locus centromeric to BRCA1 at 17q21.

Authors:  J M Rommens; F Durocher; J McArthur; P Tonin; J F LeBlanc; T Allen; C Samson; L Ferri; S Narod; K Morgan
Journal:  Genomics       Date:  1995-08-10       Impact factor: 5.736

5.  Rare mutations in XRCC2 increase the risk of breast cancer.

Authors:  D J Park; F Lesueur; T Nguyen-Dumont; M Pertesi; F Odefrey; F Hammet; S L Neuhausen; E M John; I L Andrulis; M B Terry; M Daly; S Buys; F Le Calvez-Kelm; A Lonie; B J Pope; H Tsimiklis; C Voegele; F M Hilbers; N Hoogerbrugge; A Barroso; A Osorio; G G Giles; P Devilee; J Benitez; J L Hopper; S V Tavtigian; D E Goldgar; M C Southey
Journal:  Am J Hum Genet       Date:  2012-03-29       Impact factor: 11.025

6.  Variable promoter usage and alternative splicing in five mouse connexin genes.

Authors:  Curtis L Anderson; Michael A Zundel; Rudolf Werner
Journal:  Genomics       Date:  2005-02       Impact factor: 5.736

7.  Positive role of the mammalian TBPIP/HOP2 protein in DMC1-mediated homologous pairing.

Authors:  Rima Enomoto; Takashi Kinebuchi; Makoto Sato; Hideshi Yagi; Takehiko Shibata; Hitoshi Kurumizaka; Shigeyuki Yokoyama
Journal:  J Biol Chem       Date:  2004-06-10       Impact factor: 5.157

8.  Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.

Authors:  Sean V Tavtigian; Peter J Oefner; Davit Babikyan; Anne Hartmann; Sue Healey; Florence Le Calvez-Kelm; Fabienne Lesueur; Graham B Byrnes; Shu-Chun Chuang; Nathalie Forey; Corinna Feuchtinger; Lydie Gioia; Janet Hall; Mia Hashibe; Barbara Herte; Sandrine McKay-Chopin; Alun Thomas; Maxime P Vallée; Catherine Voegele; Penelope M Webb; David C Whiteman; Suleeporn Sangrajrang; John L Hopper; Melissa C Southey; Irene L Andrulis; Esther M John; Georgia Chenevix-Trench
Journal:  Am J Hum Genet       Date:  2009-09-24       Impact factor: 11.025

Review 9.  Cytoplasmic functions of the tumour suppressor p53.

Authors:  Douglas R Green; Guido Kroemer
Journal:  Nature       Date:  2009-04-30       Impact factor: 49.962

10.  Characterization of two novel BRCA1 germ-line mutations involving splice donor sites.

Authors:  M S Brose; P Volpe; K Paul; J E Stopfer; T A Colligon; K A Calzone; B L Weber
Journal:  Genet Test       Date:  2004
View more
  13 in total

1.  Dynamic interactions of the homologous pairing 2 (Hop2)-meiotic nuclear divisions 1 (Mnd1) protein complex with meiotic presynaptic filaments in budding yeast.

Authors:  J Brooks Crickard; Youngho Kwon; Patrick Sung; Eric C Greene
Journal:  J Biol Chem       Date:  2018-11-12       Impact factor: 5.157

2.  Oncoprotein GT198 vaccination delays tumor growth in MMTV-PyMT mice.

Authors:  Bhagelu R Achyut; Hao Zhang; Kartik Angara; Nahid F Mivechi; Ali S Arbab; Lan Ko
Journal:  Cancer Lett       Date:  2020-02-12       Impact factor: 8.679

3.  Human ovarian cancer stroma contains luteinized theca cells harboring tumor suppressor gene GT198 mutations.

Authors:  Min Peng; Hao Zhang; Lahcen Jaafar; John I Risinger; Shuang Huang; Nahid F Mivechi; Lan Ko
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

4.  The ectopic expression of meiCT genes promotes meiomitosis and may facilitate carcinogenesis.

Authors:  Jennifer Gantchev; Amelia Martínez Villarreal; Scott Gunn; Monique Zetka; Neils Ødum; Ivan V Litvinov
Journal:  Cell Cycle       Date:  2020-03-30       Impact factor: 4.534

5.  GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer.

Authors:  Zheqiong Yang; Min Peng; Liang Cheng; Kimya Jones; Nita J Maihle; Nahid F Mivechi; Lan Ko
Journal:  Am J Pathol       Date:  2016-03-18       Impact factor: 4.307

6.  Significance of ligand interactions involving Hop2-Mnd1 and the RAD51 and DMC1 recombinases in homologous DNA repair and XX ovarian dysgenesis.

Authors:  Weixing Zhao; Patrick Sung
Journal:  Nucleic Acids Res       Date:  2015-03-27       Impact factor: 16.971

Review 7.  Connecting by breaking and repairing: mechanisms of DNA strand exchange in meiotic recombination.

Authors:  Christopher L Sansam; Roberto J Pezza
Journal:  FEBS J       Date:  2015-05-20       Impact factor: 5.542

8.  Genetic network and gene set enrichment analyses identify MND1 as potential diagnostic and therapeutic target gene for lung adenocarcinoma.

Authors:  Jinying Wei; Guangping Meng; Jing Wu; Qiang Zhang; Jie Zhang
Journal:  Sci Rep       Date:  2021-05-03       Impact factor: 4.379

9.  Malignant pericytes expressing GT198 give rise to tumor cells through angiogenesis.

Authors:  Liyong Zhang; Yan Wang; Mohammad H Rashid; Min Liu; Kartik Angara; Nahid F Mivechi; Nita J Maihle; Ali S Arbab; Lan Ko
Journal:  Oncotarget       Date:  2017-05-25

10.  GT198 (PSMC3IP) germline variants in early-onset breast cancer patients from hereditary breast and ovarian cancer families.

Authors:  Stephanie Schubert; Tim Ripperger; Melanie Rood; Anthony Petkidis; Winfried Hofmann; Hildegard Frye-Boukhriss; Marcel Tauscher; Bernd Auber; Ursula Hille-Betz; Thomas Illig; Brigitte Schlegelberger; Doris Steinemann
Journal:  Genes Cancer       Date:  2017-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.